Get started
Author

Marilina Puente-Hernandez

Observed names: M. Puente-Hernandez, Marilina Puente Hernández
ORCID: 0000-0002-1648-3102
Observed ORCID: 0000-0002-1648-3102
OpenAlex ID: A5013225789
Evidence of publication bias in multiple sclerosis clinical trials: a comparative analysis of published and unpublished studies registered in ClinicalTrials.gov
2023 · Alejandro Rivero-de-Aguilar, Mónica Pérez-Ríos, et al. · Journal of Neurology Neurosurgery & Psychiatry · 10
Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study
2025 · Alejandro Rivero-de-Aguilar, Mónica Pérez-Ríos, et al. · Therapeutic Advances in Neurological Disorders · 3
Cancer-associated spinal cord infarction: A systematic review and analysis of survival predictors
2023 · Marilina Puente-Hernandez, Alejandro Rivero-de-Aguilar, et al. · Journal of the Neurological Sciences · 3
Neurotological emergencies: a narrative review
2023 · Alejandro Rivero-de-Aguilar, Andrés Soto-Varela, et al. · European Archives of Oto-Rhino-Laryngology · 1
Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis
2025 · A. Rivero-de-Aguilar, M. Mascareñas-García, et al. · Neurología (English Edition)
Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis
2025 · A. Rivero-de-Aguilar, M. Mascareñas-García, et al. · Neurología
Temporal trends on the incidence of multiple sclerosis in Santiago de Compostela (Spain)
2018 · Eva Costa Arpín, Jose Maria O. Prieto, et al.
Hemorragia vítrea bilateral asociada a hemorragia pontomesencefálica: un caso extremo de síndrome de Terson
2018 · Marilina Puente Hernández, Juan Manuel Pías Peleteiro, et al. · Revista de Neurología
Mental processment velocity in patients on treatment with Fampridine
2017 · Marilina Puente Hernández
Works count: 9
Citation count: 17
H-index: 3
I10-index: 1
Year
Topic
Type